PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954583
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954583
The global ovulation testing kits market size was valued at USD 266.4 million in 2025 and is projected to grow from USD 282.9 million in 2026 to USD 489.7 million by 2034, exhibiting a CAGR of 7.10% during the forecast period (2026-2034). North America dominated the market with a 74.20% share in 2025, primarily due to the high prevalence of Polycystic Ovary Syndrome (PCOS), strong awareness regarding fertility health, and widespread adoption of at-home testing solutions.
Ovulation testing kits are diagnostic tools designed to help women track their menstrual cycle and determine their fertility window. These kits typically detect luteinizing hormone (LH) surge or progesterone metabolites, helping women plan pregnancy more effectively. They are widely used among women experiencing irregular ovulation, particularly those suffering from PCOS.
COVID-19 IMPACT
During the COVID-19 outbreak in 2020, the market experienced slow growth due to supply chain disruptions, limited product availability, and reduced visits to gynecologists. However, in the second half of 2020, demand rebounded significantly as consumers increasingly preferred home-based fertility monitoring solutions. This shift toward self-testing and telehealth-supported diagnostics positively influenced long-term market growth.
MARKET TRENDS
Increasing Focus on New Product Launches and Collaborations
Growing awareness regarding PCOS and fertility tracking has encouraged companies to introduce innovative products. Market players are increasingly launching digital and app-connected ovulation kits that offer accurate, quick, and easy-to-interpret results.
For instance, in May 2023, Fridababy, LLC launched a new line of fertility products, including an ovulation prediction test and ovulation & pregnancy tracking kits. Similarly, in July 2023, Proov collaborated with Quest Diagnostics Incorporated to expand access to Confirm PdG, an at-home fertility testing kit. Such initiatives are enhancing product availability and boosting global adoption.
MARKET GROWTH FACTORS
Increasing Prevalence of PCOS
Polycystic Ovary Syndrome (PCOS) is a leading hormonal disorder affecting reproductive-aged women, often causing irregular menstrual cycles and infertility. According to the World Health Organization (WHO) (June 2023), PCOS affects approximately 8-13% of women globally and is one of the leading causes of infertility.
In India, as per the National Center for Biotechnology Information (NCBI) (2022), the prevalence of PCOS was around 10% among women aged 15-45 years as per the Androgen Excess Society (AES), and 5.8% as per the National Institutes of Health (NIH). This rising prevalence is significantly driving demand for ovulation testing kits.
Additionally, ovulation kits offer high accuracy levels. According to Cloudnine Fertility (November 2022), ovulation prediction kits can be around 97% accurate, which further supports their adoption.
RESTRAINING FACTORS
Clinical Limitations and Risk of False Results
Despite their benefits, ovulation testing kits have certain limitations. According to an article published by Dotdash Meredith (June 2023), ovulation tests may provide inaccurate results when used alongside medications such as hormonal birth control, fertility drugs, or antibiotics containing tetracycline.
Moreover, while ovulation kits can detect LH surge with up to 99% effectiveness, they cannot confirm ovulation or guarantee pregnancy. Since these kits only track ovulation and not egg viability, their limitations may hinder broader adoption.
MARKET SEGMENTATION ANALYSIS
By Device Type
The market is segmented into digital devices, line indicator devices, and microscopic devices.
By Sample Type
Based on sample type, the market is segmented into blood, urine, and saliva.
By End-User
The market is segmented into fertility centers, hospitals & clinics, and others.
REGIONAL INSIGHTS
North America
North America accounted for the largest market share in 2025 (74.20%). The regional market is estimated to reach USD 210.4 million in 2026, driven by high PCOS prevalence and strong awareness of fertility testing.
Europe
Europe holds a substantial market share due to the presence of key players such as Geratherm Medical AG and SPD Swiss Precision Diagnostics GmbH. The region benefits from advanced healthcare infrastructure and fertility treatment adoption.
Asia Pacific
Asia Pacific is projected to witness significant growth during the forecast period due to rising infertility cases in China and India, increasing awareness, and expanding access to digital health solutions.
Rest of the World
The market in other regions is expected to grow steadily due to the increasing penetration of global manufacturers into untapped markets.
KEY INDUSTRY PLAYERS
Major companies operating in the market include:
These companies focus on mergers, acquisitions, partnerships, and product innovation to strengthen their market presence.
KEY INDUSTRY DEVELOPMENTS
CONCLUSION
The global ovulation testing kits market is expected to grow from USD 266.4 million in 2025 to USD 489.7 million by 2034, rising at a CAGR of 7.10%. The market will expand to USD 282.9 million in 2026, driven by increasing PCOS prevalence, rising awareness about fertility health, and strong demand for home-based digital testing solutions. While limitations related to accuracy and medication interference remain challenges, ongoing product innovations, digital integration, and expanding fertility clinics are expected to sustain long-term market growth through 2034.
Segmentation By Device Type
By Sample Type
By End-User
By Region